These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36792446)

  • 1. Bridging biological cfDNA features and machine learning approaches.
    Moser T; Kühberger S; Lazzeri I; Vlachos G; Heitzer E
    Trends Genet; 2023 Apr; 39(4):285-307. PubMed ID: 36792446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.
    Meriranta L; Pitkänen E; Leppä S
    Semin Hematol; 2023 Jul; 60(3):132-141. PubMed ID: 37455222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
    Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
    Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pocket companion to cell-free DNA (cfDNA) preanalytics.
    Bronkhorst AJ; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S297-S308. PubMed ID: 37840517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing of cell-free DNA - A systematic review and Bayesian individual patient data meta-analysis.
    Bos MK; Angus L; Nasserinejad K; Jager A; Jansen MPHM; Martens JWM; Sleijfer S
    Cancer Treat Rev; 2020 Feb; 83():101951. PubMed ID: 31874446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free DNA in cancer: current insights.
    Fettke H; Kwan EM; Azad AA
    Cell Oncol (Dordr); 2019 Feb; 42(1):13-28. PubMed ID: 30367445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization.
    Nguyen VTC; Nguyen TH; Doan NNT; Pham TMQ; Nguyen GTH; Nguyen TD; Tran TTT; Vo DL; Phan TH; Jasmine TX; Nguyen VC; Nguyen HT; Nguyen TV; Nguyen THH; Huynh LAK; Tran TH; Dang QT; Doan TN; Tran AM; Nguyen VH; Nguyen VTA; Ho LMQ; Tran QD; Pham TTT; Ho TD; Nguyen BT; Nguyen TNV; Nguyen TD; Phu DTB; Phan BHH; Vo TL; Nai THT; Tran TT; Truong MH; Tran NC; Le TK; Tran THT; Duong ML; Bach HPT; Kim VV; Pham TA; Tran DH; Le TNA; Pham TVN; Le MT; Vo DH; Tran TMT; Nguyen MN; Van TTV; Nguyen AN; Tran TT; Tran VU; Le MP; Do TT; Phan TV; Nguyen HL; Nguyen DS; Cao VT; Do TT; Truong DK; Tang HS; Giang H; Nguyen HN; Phan MD; Tran LS
    Elife; 2023 Oct; 12():. PubMed ID: 37819044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy in lymphoma: Molecular methods and clinical applications.
    Cirillo M; Craig AFM; Borchmann S; Kurtz DM
    Cancer Treat Rev; 2020 Dec; 91():102106. PubMed ID: 33049623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
    Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
    J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomics.
    Wang F; Li X; Li M; Liu W; Lu L; Li Y; Chen X; Yang S; Liu T; Cheng W; Weng L; Wang H; Lu D; Yao Q; Wang Y; Wu J; Wittkop T; Faham M; Zhou H; Hu H; Jin H; Hu Z; Ma D; Cheng X
    Clin Chem Lab Med; 2024 Jan; 62(1):168-177. PubMed ID: 37678194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
    Kerachian MA; Poudineh A; Thiery JP
    Crit Rev Oncol Hematol; 2019 Dec; 144():102827. PubMed ID: 31715326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Circulating Cell-Free DNA to Guide Precision Medicine in Patients with Colorectal Cancer.
    Morris VK; Strickler JH
    Annu Rev Med; 2021 Jan; 72():399-413. PubMed ID: 33502901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas.
    Braig D; Becherer C; Bickert C; Braig M; Claus R; Eisenhardt AE; Heinz J; Scholber J; Herget GW; Bronsert P; Fricke A; Follo M; Stark GB; Bannasch H; Eisenhardt SU
    Int J Cancer; 2019 Aug; 145(4):1148-1161. PubMed ID: 30779112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragmentomic analysis of circulating tumor DNA-targeted cancer panels.
    Helzer KT; Sharifi MN; Sperger JM; Shi Y; Annala M; Bootsma ML; Reese SR; Taylor A; Kaufmann KR; Krause HK; Schehr JL; Sethakorn N; Kosoff D; Kyriakopoulos C; Burkard ME; Rydzewski NR; Yu M; Harari PM; Bassetti M; Blitzer G; Floberg J; Sjöström M; Quigley DA; Dehm SM; Armstrong AJ; Beltran H; McKay RR; Feng FY; O'Regan R; Wisinski KB; Emamekhoo H; Wyatt AW; Lang JM; Zhao SG
    Ann Oncol; 2023 Sep; 34(9):813-825. PubMed ID: 37330052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
    Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
    Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
    [No Abstract]   [Full Text] [Related]  

  • 18. Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA.
    Gawroński AR; Lin YY; McConeghy B; LeBihan S; Asghari H; Koçkan C; Orabi B; Adra N; Pili R; Collins CC; Sahinalp SC; Hach F
    Nucleic Acids Res; 2019 Apr; 47(7):e38. PubMed ID: 30759232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
    Luo H; Wei W; Ye Z; Zheng J; Xu RH
    Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cell-free tumor DNA analysis in pediatric cancers.
    Andersson D; Fagman H; Dalin MG; Ståhlberg A
    Mol Aspects Med; 2020 Apr; 72():100819. PubMed ID: 31563277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.